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Summary
The cell wall mycolyl-arabinogalactan–peptidoglycan
complex is essential in mycobacterial species, such
as Mycobacterium tuberculosis and is the target of
several antitubercular drugs. For instance, ethambu-
tol targets arabinogalactan biosynthesis through inhi-
bition of the arabinofuranosyltransferases Mt-EmbA
and Mt-EmbB. A bioinformatics approach identiﬁed
putative integral membrane proteins, MSMEG2785 in
Mycobacterium smegmatis, Rv2673 in Mycobacte-
rium tuberculosis and NCgl1822 in Corynebacterium
glutamicum, with 10 predicted transmembrane
domains and a glycosyltransferase motif (DDX),
features that are common to the GT-C superfamily
of glycosyltransferases. Deletion of M. smegmatis
MSMEG2785 resulted in altered growth and glycosyl
linkage analysis revealed the absence of AG a(1,3)-
linked arabinofuranosyl (Araf) residues. Complemen-
tation of the M. smegmatis deletion mutant was fully
restored to a wild-type phenotype by MSMEG2785
and Rv2673, and as a result, we have now termed
this previously uncharacterized open reading frame,
arabinofuranosyltransferase C (aftC). Enzyme as-
says using the sugar donor b-D-arabinofuranosyl-1-
monophosphoryl-decaprenol (DPA) and a newly syn-
thesized linear a(1,5)-linked Ara5 neoglycolipid
acceptor together with chemical identiﬁcation of
products formed, clearly identiﬁed AftC as a branch-
ing a(1,3) arabinofuranosyltransferase. This newly
discovered glycosyltransferase sheds further light on
the complexities of Mycobacterium cell wall biosyn-
thesis, such as in M. tuberculosis and related species
and represents a potential new drug target.
Introduction
Tuberculosis (TB) affects a third of the world population
and causes 1.8 million fatalities annually (Dye, 2006). The
spread ofTB has been facilitated in recent years due to the
susceptibility of HIV-infected individuals to Mycobacterium
tuberculosis, the aetiological agent of TB (Paolo and
Nosanchuk, 2004). The problem has also been com-
pounded by the emergence of multidrug-resistant TB
(MDR-TB)(KayeandFrieden,1996)andextensivelydrug-
resistant (XDR)-TB strains (Shah et al., 2007). M. tubercu-
losis and other mycobacteria have a distinct cell wall which
has a lipid-rich outer layer that is highly impermeable
(Minnikin, 1982). One of the major components of this
outer envelope are mycolic acids, long-chain a-alkyl,
b-hydroxyfattyacidsthatareessentialforbacterialsurvival
(Vilcheze et al., 2000; Portevin et al., 2004; Bhatt et al.,
2005;Parishet al.,2007).Thesearefoundeitheresteriﬁed
to the non-reducing termini of arabinogalactan (AG), or are
present as trehalose esters, such as trehalose dimycolate
(TDM) (Brennan and Nikaido, 1995; Dover et al., 2004).
A common feature of members of the Corynebacteria-
neae is that they all possess this unusual cell wall archi-
tecture (McNeil et al., 1990; 1991; Besra et al., 1995).
Apart from mycolic acids, the cell wall is dominated by a
second macromolecule, an essential heteropolysaccha-
ride termed AG, which is linked to both mycolic acids and
peptidoglycan, forming the mycolyl-arabinogalactan–
peptidoglycan(mAGP)complex(Dafféet al.,1990;McNeil
et al., 1990; 1991; Besra et al., 1995).The formation of the
arabinan domain (a1→5, a1→3 and b1→2 glycosyl link-
ages) of AG results from the subsequent addition of ara-
binofuranose (Araf) residues by a set of unique
arabinofuranosyltransferases including, the Emb proteins
of which three paralogues exist in Mycobacterium
avium (Belanger et al., 1996) and M. tuberculosis (Telenti
et al.,1997),AftA(Alderwicket al.,2006a)andAftB(Seidel
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arabinofuranosyl-1-monophosphoryldecaprenol (DPA;
Wolucka et al., 1994; Lee et al., 1995; 1997) serves as the
substrate molecule for these complex membrane-bound
glycosyltransferases.
The antituberculosis drug ethambutol (EMB) was shown
to speciﬁcally inhibit AG biosynthesis (Takayama and
Kilburn, 1989). The precise molecular target of EMB occu-
pies the embCAB locus in M. tuberculosis (Telenti et al.,
1997).To further deﬁne the role of EmbCAB proteins in cell
wall arabinan biosynthesis, embA, embB and embC were
individually inactivated in Mycobacterium smegmatis
(Escuyeret al.,2001;Zhanget al.,2003).Allthreemutants
were viable; however, the non-reducing terminalAra6 motif
which is the template for mycolylation inAG (McNeil et al.,
1991) was altered in both the M. smegmatis (Ms)-embA
and Ms-embB mutants (Escuyer et al., 2001), while
Ms-embC was shown to be involved in the formation of the
arabinan domains of lipoarabinomannan (LAM; Zhang
et al., 2003). Attempts to obtain deletion mutants of embA
(Amin et al., 2008) and embB in M. tuberculosis and
embAB in M. smegmatis have proved unsuccessful (G.S.
Besra, unpubl. results). In contrast, deletion of the single
C. glutamicum (Cg)-emb orthologue and chemical analy-
sis of the cell wall revealed a novel truncatedAG structure
possessing only terminal (t)-Araf residues with a corre-
sponding loss of cell wall-bound mycolic acids (Alderwick
et al., 2005). The presence of a novel enzyme responsible
for ‘priming’ the galactan domain for further elaboration by
Emb proteins led to the identiﬁcation of AftA (Alderwick
et al., 2006a). Recently, a retaining GT-C enzyme was
identiﬁed, now termed AftB, which is responsible for the
attachment of terminal b(1→2) Araf residues, and marks
the ‘end-point’forAG arabinan biosynthesis (Fig. 1) before
decoration with mycolic acids (Seidel et al., 2007a).
It is clear that additional arabinofuranosyltransferases
involved in AG and LAM biosynthesis still remain to be
identiﬁed. Indeed, Liu and Mushegian (2003) identiﬁed 15
members of the GT-C superfamily residing in M. tubercu-
losis, representing candidates involved in the biosynthesis
of cell wall-related glycans and lipoglycans (Liu and Mush-
egian,2003).Wehavecontinuedourearlierstudies(Alder-
wick et al., 2006a,b; Seidel et al., 2007a) to identify genes
required for the biosynthesis of the core structural ele-
ments of the mAGP complex by studying mutants of
M. smegmatis and the orthologous genes and enzymes of
M. tuberculosisandCorynebacteriumglutamicum.Herein,
wepresentMSMEG2785,Rv2673andNCgl1822asanew
distinct arabinofuranosyltransferase of the GT-C super-
family,whichisresponsibleforthetransferofArafresidues
from DPA to the arabinan domain to form a(1→3)-linked
Araf residues, which result in the branched arabinan
domain distal to the non-reducing terminalAra6 motif char-
acteristic of mycobacterial AG.
Results
Genome comparison of the Rv2673 locus
The arabinofuranosyltransferases EmbA, EmbB and
EmbC are vital for M. tuberculosis and represent a target
for the established drug EMB (Mikusova et al., 1995;
Belanger et al., 1996; Telenti et al., 1997). Structural con-
siderations of these proteins and a search for new drug
targets resolved that more than 16 related proteins are
Fig. 1. Biosynthetic pathway leading to arabinan formation in
M. tuberculosis AG.
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syltransferases (Liu and Mushegian, 2003). In our sys-
tematic analysis of GT-C glycosyltransferases, focusing
on those present in M. tuberculosis and C. glutamicum,
we have previously identiﬁed the arabinofuranosyltrans-
ferases AftA (Alderwick et al., 2006a) and AftB (Seidel
et al., 2007a), as well as several a-mannosyltransferases
(Mishra et al., 2007; 2008). Each of these glycosyltrans-
ferases plays a speciﬁc yet decisive role in cell wall bio-
synthesis and assembly. In silico analysis of one of the
putative glycosyltransferases of M. tuberculosis, Rv2673,
highlighted that orthologues are present in a range of
species belonging to the suborder Corynebacterianeae,
including the families Mycobacteriaceae, Corynebacteria-
cea and Nocardiaceae (Fig. 2A). Furthermore, the orga-
nization of the gene locus is largely retained. The adjacent
genes are largely of unknown function. RibD encodes a
bifunctional deaminase–reductase domain, followed by a
gene product containing a hydrolase domain, which is
however, absent in Corynebacterium, and downstream of
Rv2673 a gene of unknown function is present. The wide
distribution of Rv2673, its syntenic organization, and the
fact that it is retained even in M. leprae, strongly indicates
a fundamental function of its product. According to our
experimental analysis (see below) we annotated this gene
arabinofuranosyltransferase C (aftC).
AftC of M. tuberculosis is 433 amino acid residues long.
It is a hydrophobic protein and is predicted to possess 10
transmembrane-spanning segments (Fig. 2B). However,
in contrast toAftA,AftB or EmbC, it is characterized by the
absence of a periplasmic carboxyterminal extension. The
amino acid sequence among the Corynebacterianeae is
very well conserved, and there are 43% identical residues
shared by the M. tuberculosis and C. glutamicum proteins.
The degree of conservation is particularly high in the loop
regions, for instance between helixes 1 and 2, 3 and 4, or
6 and 7 (Fig. 2B). The fully conserved aspartyl (D) and
glutamyl (E) residues, which we propose to be involved in
catalysis or substrate binding, are located in the ﬁrst
extended loop region (Liu and Mushegian, 2003), as we
have demonstrated for similarly located aspartyl (D) resi-
dues of Cg-Emb andAftB (Seidel et al., 2007a,b). Interest-
ingly, the long transmembrane helix 8 is well conserved
and it is within this region that there is a strong identity to a
membrane protein of Vibrio parahaemolyticus (CpsG).
Furthermore,thisgeneislocatedinageneclusterinvolved
in the biosynthesis of a capsular polysaccharide within this
pathogen (Guvener and McCarter, 2003).
Construction and growth of mutants
In order to delete aftC and study for possible conse-
quences we generated a null mutant of M. smegmatis
mc2155 MSMEG2785 (orthologue of Rv2673) using
specialized transduction (Fig. 3A). In contrast to
our C. glutamicum studies (see below) growth of
M. smegmatisDaftC in comparison to M. smegmatis was
poorinliquidmedium(Fig. 3B)andsensitivetotheaddition
of Tween-80 on agar plates (> 0.005%). Complementation
Fig. 2. Comparison of the aftC locus within the
Corynebacterianeae.
A. The locus in the bacteria analysed consists of aftC which in
M. tuberculosis has the locus tag Rv2673 and in C. glutamicum
NCgl1822. The genomic region displayed encompasses 7 kb, and
orthologous genes are highlighted accordingly. M. marinum,
Mycobacterium marinum; M. av ssp. par., Mycobacterium avium
ssp. paratuberculosis; C. efficiens, Corynebacterium efficiens;
C. jeikeium, Corynebacterium jeikeium; Nocardia farcina, Nocardia
farcina IFM 10 152; Rhodococcus, Rhodococcus sp. strain RHA1.
B. AftC is a hydrophobic protein predicted to span the membrane
10 times and the transmembrane helices are numbered
accordingly. The lower part of the ﬁgure shows the degree of
conservation of the orthologues given in A as analysed by the
DIALIGN method (Brudno et al., 2003). Also shown is the
approximate position of the fully conserved aspartyl (D) and
glutamyl (E) residues.
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pMV261-M. tuberculosis(Mt)-aftCrestoredthemutanttoa
wild-type phenotype (Fig. 3B). On solid media M. smeg-
matisDaftC had a smooth and glossy appearance in com-
parison to the typical crenulated colony morphology found
for wild-type M. smegmatis (Fig. 3C) and failed to stain as
‘acid-fast’ positive (data not shown). In addition, suscepti-
bility of M. smegmatisDaftC to EMB and the hydrophobic
antibiotics rifampicin and chloramphenicol was enhanced
(minimal inhibitory concentration of 2, 100 and 10 mgm l -1
for wild-type M. smegmatis in comparison to 0.4, 4 and
5 mgm l -1 for M. smegmatisDaftC respectively), indicating
increased permeability and that M. smegmatisDaftC had
an altered cell wall.To study the function of the corynebac-
terialAftCthenon-replicativeplasmidpK19mobsacBDaftC
was constructed. This was used to transform
C. glutamicumtokanamycinresistance,indicatingintegra-
tion in its chromosome (Fig. S1A). Loss of vector was
obtained by selection for sucrose-resistance yielding
clones with aftC deleted.APCR analysis with primer pairs
P5andP6resultedintheexpectedfragmentof2160 bpfor
the wild-type and of 1065 bp for the deletion mutant, which
was termed C. glutamicumDaftC. Colonies of this mutant
were more erose compared with the usual glossy appear-
anceofthewild-typecolony(datanotshown).Incontrastto
M. smegmatisDaftC the growth of the C. glutamicumDaftC
mutantonthesaltmediumCGXIIpossessedonlyaslightly
reduced growth rate of 0.32 h-1, whereas, that of the wild-
type C. glutamicum was 0.39-1 h (Fig. S1B).
mAGP analyses from M. smegmatis,
M. smegmatisDaftC, M. smegmatisDaftC
pMV261-Ms-aftC, M. smegmatisDaftC pMV261-Mt-aftC,
C. glutamicum and C. glutamicumDaftC
To study the function of mycobacterial aftC deletion, defat-
ted cells were analysed qualitatively for AG esteriﬁed
mycolic acids and cell wall-associated lipids from an
equivalent starting amount of biomass for each strain due
to differences in growth rate (Fig. 3B). As expected,
M. smegmatis exhibited a typical proﬁle of cell wall-bound
a, a′ and epoxy-mycolic acid methyl esters (MAMEs),
whereas, these products were drastically reduced in
M. smegmatisDaftC (Fig. 4A). In addition, complementa-
tion of M. smegmatisDaftC with either pMV261-Ms-aftC or
pMV261-Mt-aftC (Fig. 4A), led to the restoration of normal
‘levels’ of cell wall-bound mycolic acids. Analysis of cell
wall-associated lipids in several independent experiments
highlighted an apparent increase in TDM for the aftC
deletion mutant. This was conﬁrmed quantitatively
through [14C]acetate labelling of cultures and equal
loading of radioactivity of extractable free lipids from
M. smegmatis, M. smegmatisDaftC and the comple-
mented M. smegmatisDaftC strain using plasmids
pMV261-Ms-aftC and pMV261-Mt-aftC (Fig. 4B). Typi-
cally, wild-type M. smegmatis synthesized 5250 cpm,
whereas M. smegmatisDaftC afforded 14 676 cpm of
TDM after equivalent loading of radioactivity and quanti-
tative analysis by phosphorimaging. Complementation of
M. smegmatisDaftC with either pMV261-Ms-aftC or
pMV261-Mt-aftC restored the phenotype of the deletion
mutant back to that of wild-type M. smegmatis (Fig. 4B).
These results demonstrated that Ms-aftC and Mt-aftC are
involved in a key aspect of arabinan biosynthesis,
whereby deletion substantially perturbs tethering of
mycolic acids to AG, which results in an increase in TDM
production.
The cell wall core (mAGP) was prepared from
M. smegmatis and M. smegmatisDaftC as described
(Daffé et al., 1990; Besra et al., 1995; Alderwick et al.,
2005) and the ratio of Ara to Gal in mAGP determined by
gas chromatography (GC) analysis of alditol acetates
(Daffé et al., 1990; Besra et al., 1995; Escuyer et al.,
2001; Alderwick et al., 2005) (Fig. 5). The glycosyl com-
position was calculated based on a single rhamnosyl
(Rha) residue per AG chain (McNeil et al., 1990). The
glycosyl compositional analysis revealed a relative molar
ratio of Rha : Ara : Gal of 1:71:31 and an Ara : Gal ratio of
2.3:1, which is in accord with previous data (Escuyer
et al., 2001). The M. smegmatisDaftC mutant yielded AG
with a signiﬁcant reduction in Ara content concomitant
with a relative increase in the amount of Gal. The
M. smegmatisDaftC yielded anAG with an Rha : Ara : Gal
ratio of 1:22:56 and an Ara : Gal ratio of 0.4:1. Comple-
mentation of M. smegmatisDaftC with either pMV261-Ms-
aftC or pMV261-Mt-aftC, restored the Rha : Ara : Gal ratio
to that of wild-type M. smegmatis. Gas chromatography
mass spectrometry (GC/MS) analysis of per-O-
Fig. 3. Generation of a MSMEG2785 null mutant.
A. A map of the MSMEG2785 region in the parental M. smegmatis strain and its corresponding region in the DMSMEG2785 mutant. res, gd
resolvase site; hyg, hygromycin resistance gene from Streptomyces hygroscopicus; sacB, sucrose counter-selectable gene from Bacillus
subtilis. Digoxigenin-labelled probes were derived from ~1 kb upstream and downstream ﬂanking sequences that were used to construct the
knockout plasmid, and are indicated by thick lines with square ends. SacI-digested bands expected in a Southern blot are indicated in roman
numerals with sizes in brackets. The inset shows the Southern blot of SacI-digested genomic DNA from the two strains with expected bands
indicated by arrows.
B. Growth of wild-type M. smegmatis (), M. smegmatisDaftC (), M. smegmatisDaftC pMV261-Ms-aftC () and M. smegmatisDaftC
pMV261-Mt-aftC () in TSB medium.
C. Colony morphology of wild-type M. smegmatis and M. smegmatisDaftC on TSB-agar plates. Black bar represents 1 mm.
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M. smegmatis and M. smegmatisDaftC indicated the
complete absence of 3,5-Araf branching residues and a
signiﬁcant reduction in t-Araf, 2-Araf and 5-Araf-linkages
(Fig. 6). Complementation of M. smegmatisDaftC with
either plasmid encoding Ms-aftC or Mt-aftC restored the
glycosyl linkage proﬁle to that of wild-type M. smegmatis
(Fig. 6). These results demonstrate that MSMEG2785
and Rv2673 are functionally equivalent and are involved
in the synthesis of 3,5-Araf branching residues. Interest-
ingly, LAM preparations from M. smegmatisDaftC were
truncated in size on SDS-PAGE analysis to ‘full-size’ LAM
from wild-type M. smegmatis. Further puriﬁcation and
detailed chemical analyses of LAM from the aftC mutant
strain are currently being undertaken and will be reported
separately (H.L. Birch, unpubl. results).
Incontrasttothemycolicacidstudiesperformedwiththe
mycobacterial aftC deletion mutant, C. glutamicumDaftC
cellswereanalysedquantitativelyforAGesteriﬁedcoryne-
mycolic acids due to similar growth rates between strains
(Fig. S1B). Wild-type C. glutamicum exhibited the known
proﬁle of corynomycolic acid methyl esters (CMAMEs,
35 345 cpm; Fig. S2), whereas, cell wall-bound CMAMEs
were signiﬁcantly reduced in C. glutamicumDaftC
(8023 cpm). The above data were reassuring as the
qualitative (M. smegmatisDaftC) and quantitative
(C. glutamicumDaftC) analyses were comparable in
terms of a reduction in cell wall-bound mycolic acids
(Fig. 4A and Fig. S2). Importantly, these results have also
shown that Cg-aftC is involved in a key aspect of arabinan
biosynthesis, whereby deletion perturbs tethering of
corynomycolic acids to AG. The GC/MS proﬁles of per-
O-methylated alditol acetate derivatives of C. glutamicum
and C. glutamicumDaftC are shown in Fig. S3 with
C. glutamicumDaftC also clearly devoid of 3,5-Araf
branching residues.
In vitro arabinofuranosyltransferase activity with extracts
of M. smegmatis, M. smegmatisDaftC and
complemented strains
Initial attempts to develop an in vitro assay using either
puriﬁedrecombinantexpressedAftCorE. colimembranes
expressing aftC, have thus far proved unsuccess-
ful, probably due to the hydrophobic nature of the
protein. In an alternative approach, we assessed the
capacity of membrane preparations from M. smegmatis,
M. smegmatisDaftC and M. smegmatisDaftC comple-
Fig. 4. Analysis of cell wall-associated lipids and bound MAMEs
from M. smegmatis, M. smegmatisDaftC, M. smegmatisDaftC
pMV261-Ms-aftC and M. smegmatisDaftC pMV261-Mt-aftC.
A. Analysis of cell wall-bound MAMEs from M. smegmatis,
M. smegmatisDaftC, M. smegmatisDaftC pMV261-Ms-aftC and
M. smegmatisDaftC pMV261-Mt-aftC. The bound mycolic acids
from an equivalent amount of freeze-dried cells (100 mg), which
were initially de-lipidated using two consecutive extractions of
CHCl3/CH3OH/H2O (10/10/3; v/v/v) at 50°C for 4 h, were released
by the addition of tetra-butylammonium hydroxide at 100°C
overnight, and methylated as described in the Experimental
procedures. An equivalent aliquot from each strain was subjected
to TLC using silica gel plates (5735 silica gel 60F254, Merck), and
developed in petroleum ether/acetone (95:5, v/v) and charred to
reveal MAMEs and compared with known standards (Gande et al.,
2004).
B. Quantitative analysis of extractable [
14C]-lipids from
M. smegmatis, M. smegmatisDaftC, M. smegmatisDaftC
pMV261-Ms-aftC and M. smegmatisDaftC pMV261-Mt-aftC. Lipids
were extracted from cells by a series of organic washes as
described in Experimental procedures (Seidel et al., 2007a). An
equivalent aliquot (50 000 cpm) from each strain was subjected to
TLC using silica gel plates (5725 silica gel 60F254, Merck)
developed in CHCl3/CH3OH/NH4OH (80:20:2, v/v/v) and quantiﬁed
using phosphorimaging and compared with known standards
(Mikusova et al., 1995) after exposure to Kodak X-Omat ﬁlm for
24 h.
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syltransferase activity in the presence of exogenous
synthetic acceptors (Lee et al., 1997; Seidel et al., 2007a).
WeﬁrstassessedwhetherM. smegmatisDaftCwasdeﬁ-
cient in a(1→5) and b(1→2) arabinofuranosyltransferase
activity using an a-D-Araf-(1→5)-a-D-Araf-O-(CH2)7CH3
(Ara2) synthetic acceptor (Lee et al., 1997) and DP[14C]A
as a sugar donor based on an established assay format for
determining a(1→5) and b(1→2) arabinofuranosyltrans-
ferase activities (Lee et al., 1998). TLC/autoradiographic
analysisoftheproductswhichwereonlysynthesizedinthe
presence ofAra2, when assayed with M. smegmatis mem-
branes resulted in the formation of two products (A and B)
(Fig. 7AandB).TheenzymaticsynthesisofproductsAand
B are consistent with our previous studies using mycobac-
terial (Lee et al., 1997) and corynebacterial (Seidel et al.,
2007a) membrane preparations resulting in trisaccharide
productsasaresultofa(1→5)andb(1→2)Araflinkagesto
the Ara2 acceptor (Fig. 7A). Addition of EMB in several
experiments, even at high concentrations of up to
1m gm l -1 to the reaction mixture, resulted in a decrease in
only the in vitro synthesized a-D-[14C]Araf-(1→5)-a-D-Araf-
(1→5)-a-D-Araf-O-(CH2)7CH3 product A (Fig. 7A and B).
Assays performed with membranes from M. smegmatis-
DaftCandthepMV261-Mt-aftCcomplementedstrainusing
the Ara2 synthetic acceptor gave a similar proﬁle to that of
wild-type M. smegmatis (Fig. 7B). The data clearly show
that the M. smegmatisDaftC strain possesses comparable
levels of EMB-sensitive a(1→5) and EMB-resistant
b(1→2) arabinofuranosyltransferase activity.
The lack of a(1→3) arabinofuranosyltransferase activity
in the previously reported Ara2 and a-D-Araf-(1→5)-a-D-
Araf-(1→5)-a-D-Araf-O-(CH2)7CH3 (Ara3) acceptor-based
assays (Lee et al., 1997) required the development
of an arabinofuranosyltransferase assay using the
Ara-extended synthetic acceptor a-D-Araf-(1→5)-a-D-
Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-O-
(CH2)8NH2 (Ara5)( Supplementary experimental and
Fig. S4) and DP[14C]Aas a sugar donor (Lee et al., 1998).
TLC/autoradiographic analysis of the products which are
only synthesized in the presence of Ara5, when assayed
with M. smegmatis membranes resulted in the formation
of a single product X (Fig. 8A) through the transfer of a
single [14C]Araf residue, with a retardation factor (Rf) con-
sistent with a synthetic Ara6 acceptor (Appelmelk et al.,
2008) standard (Fig. 8B). In addition, the synthesis of
product X in overexpression studies was enhanced. Con-
sistently from two independent membrane preparations
and assays performed in triplicate from M. smegmatis
pMV261-Mt-aftC produced product X (6453 cpm) in com-
parison to membranes from wild-type M. smegmatis
(4289 cpm) in the above assays, demonstrating that AftC
was functionally involved in the synthesis of product X.
The inclusion of EMB in several experiments, even at high
concentrations of up to 1 mg ml-1 to the reaction mixture
did not inhibit the synthesis of this in vitro synthesized
[14C]Araf-Ara5 (Fig. 8A, Product X) illustrating that theAra5
acceptor was not extended via an EMB-sensitive a(1→5)
arabinofuranosyltransferase. Interestingly, membranes
prepared from the M. smegmatisDaftC strain were unable
to synthesize the in vitro product to the same level of
activity that was observed with wild-type membranes pre-
pared from M. smegmatis (Fig. 8A). This was to be
expected, as our earlier in vivo and in vitro studies would
have anticipated residual Ara6 product formation, consid-
ering that M. smegmatisDaftC possesses b(1→2) ara-
binofuranosyltransferase activity. Assays performed with
Fig. 5. GC analysis of cell walls of M. smegmatis,
M. smegmatisDaftC, M. smegmatisDaftC pMV261-Ms-aftC and
M. smegmatisDaftC pMV261-Mt-aftC. Samples of puriﬁed cell
walls were hydrolysed with 2 M TFA, reduced, per-O-acetylated
and analysed as described under Experimental procedures
(Besra et al., 1995; Alderwick et al., 2005).
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aftC complemented strain, gave a similar proﬁle to that of
wild-type M. smegmatis (Fig. 8A).
ToestablishthattheAra5acceptorisbeingutilizedbytwo
different arabinofuranosyltransferases, presumably estab-
lishing b(1→2) and a(1→3) linkages, assays similar to that
used before were scaled up (see Experimental proce-
dures) and product X extracted and puriﬁed through
preparative TLC for each membrane preparation. GC
(Sassaki et al., 2005) and GC/MS (Alderwick et al., 2005)
analyses of the partially per-O-methylated, per-O-
acetylatedalditolacetatederivativesofproductXinassays
performed with M. smegmatis membranes revealed the
addition of b(1→2) [Rt 11.75 min; m/z 129, 130,161,190]
and a(1→3) [Rt 12.39 min; m/z 118, 129, 130, 190, 202,
233] linked Araf residues (Fig. 9A and B). Therefore, the
product migrating below Ara5 and coincident with the Ara6
acceptor standard on TLC (Fig. 8A and B) is in fact a
mixture of two products (Fig. 9B). The addition of b(1→2)-
linked Araf residues can be attributed to the function of
AftB. The presence of a(1→3)-linked Araf residues in this
assayusinganAra5acceptorclearlyhighlightstheroleofa
novel arabinofuranosyltransferase(s) capable of function-
ing in an a(1→3) capacity. Importantly, the level of a(1→3)
activity when the Ara5 acceptor is incubated with mem-
branes prepared from M. smegmatisDaftC is completely
abolished (Fig. 9A). However, b(1→2) activity is clearly
present in M. smegmatisDaftC (Fig. 9A). In addition,
M. smegmatisDaftC complemented with pMV261-Mt-aftC
restores a(1→3) arabinofuranosyltransferase activity to
wild-type M. smegmatis (Fig. 9A). The results clearly
establish both from in vivo and in vitro experiments that
AftC catalyses the addition of an a(1→3)-Araf unit via an
a(1→3) arabinofuranosyltransferase and that this enzyme
is also resistant to EMB (Fig. 8A).
Discussion
The mAGP complex represents one of the most important
cell wall components of the Corynebacterianeae and is
Fig. 6. GC/MS analysis of cell walls of M. smegmatis, M. smegmatisDaftC, M. smegmatisDaftC pMV261-Ms-aftC and M. smegmatisDaftC
pMV261-Mt-aftC. Samples of per-O-methylated cell walls were hydrolysed with 2 M TFA, reduced, per-O-acetylated and analysed as
described under Experimental procedures (Besra et al., 1995; Alderwick et al., 2005).
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et al., 2000; Pan et al., 2001; Gande et al., 2004; Mills
et al., 2004). It is therefore not surprising that one of the
most effective antimycobacterial drugs, EMB, targets its
synthesis through inhibition of AG biosynthesis. However,
the emergence of MDR-TB and XDR-TB has accelerated
the need to discover new drug targets (Brennan and
Nikaido, 1995). One of the strategies is to identify genes
involved in AG biosynthesis. Based on this strategy we
previously identiﬁed the presence of a new ‘priming’
enzyme, now termed AftA, which would link the initial Araf
unit with the C-5 OH of a b(1→6) linked Galf of a pre-
synthesized galactan core (Alderwick et al., 2005), and
more recently identiﬁed the AftB enzyme responsible for
b(1→2) Araf residues.
The previously described Emb (Alderwick et al., 2005),
AftA (Alderwick et al., 2006a) and AftB proteins (Seidel
et al., 2007a) are distinct arabinofuranosyltransferases.
Thus, despite some functional relationship, these glyco-
syltransferases have inherent speciﬁc features as evident
from the insensitivity of AftA and AftB towards EMB,
whereas the single Cg-Emb (Alderwick et al., 2005; Rad-
macher et al., 2005) and Mt-Emb proteins are sensitive
towards EMB (Telenti et al., 1997; Belanger et al., 1996).
The number of arabinofuranosyltransferases that are
required for mycobacterial arabinan biosynthesis has
been a matter of speculation to date depending on how
the arabinan chains are assembled. The primary structure
of AG (Besra et al., 1995; Daffé et al., 1990) would
suggest at least ﬁve distinct arabinofuranosyltransferases
are required for the complete formation of AG. Interest-
ingly, M. smegmatis embA and embB mutants were found
to possess reduced amounts of the non-reducing terminal
disaccharide b-D-Araf-(1→2)-a-D-Araf and result in the
removal of the dominant terminal non-reducing Ara6
branched motif in the mutant being replaced by a linear
Ara4 motif (Escuyer et al., 2001). The authors of this study
concluded that the M. smegmatis embA and embB
mutants result in a lack of 3-arm branching off the main
a(1→5)-arabinan chain proximal to the non-reducing and
attachment site of mycolic acids in AG (Escuyer et al.,
2001). Initially, it was proposed that the b-D-Araf-(1→2)-
a-D-Araf disaccharide was assembled using EmbA and
EmbB. However, the recent identiﬁcation of AftB, the
development of speciﬁc in vitro assays in combination
with mutant strains, and recent structural studies have
Fig. 7. Arabinofuranosyltransferase
activity utilizing an Ara2 acceptor and
membranes prepared from M. smegmatis,
M. smegmatisDaftC and M. smegmatisDaftC
pMV261-Mt-aftC.
A. Biosynthetic reaction scheme of products A
and B formed in arabinofuranosyltransferase
assays using the neoglycolipid Ara2 acceptor.
B. Arabinofuranosyltransferase activity was
determined using the synthetic Ara2 acceptor
in a cell-free assay with and without EMB
(1 mg ml
-1) as previously described (Lee
et al., 1997). The products of the assay were
re-suspended prior to scintillation counting
(10%) and the remaining subjected to TLC
using silica gel plates (5735 silica gel 60F254,
Merck) in CHCl3/CH3OH/H2O/NH4OH
(65/25/3.6/0.5, v/v/v/v) with the reaction
products visualized by autoradiography. The
TLC autoradiogram is representative of
several independent experiments.
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furanosyltransferases (Alderwick et al., 2005; Seidel
et al., 2007a; Bhamidi et al., 2008).
In this study, we have identiﬁed MSMEG2785 (also
Rv2673 and NCgl1822, which we have termed AftC, as a
novel branching arabinofuranosyltransferase. More pre-
cisely,AftC catalyses the addition of a(1→3)Araf residues
as shown through both in vivo and in vitro experiments,
ultimately resulting in 3,5-Araf residues after further
a(1→5) extension, characteristic of AG. For instance,
incubation of membranes prepared from M. smegmatis
with DP[14C]A and a linear a(1→5)-Ara5 neoglycolipid
acceptor resulted in the synthesis of an Ara6 product.
Further chemical characterization of the product by glyco-
syl linkage analysis established that the a(1→5)-Ara5
acceptor was extended via an EMB-resistant a(1→3) ara-
binofuranosyltransferase giving rise to 3-linked Araf resi-
dues and corroborated our earlier cell wall analysis of the
M. smegmatisDaftC mutant. As it is now established that
only a(1→5) arabinofuranosyltransferase(s) is EMB-
sensitive it can be further speculated that EmbA and
EmbB function in the assembly of the linear a(1→5) ara-
binan segments as presented in Fig. 10, which is in accor-
dance with previous data and the phenotype of a Cg-Emb
mutant (Alderwick et al., 2005). It is clear that further
studies are required to establish the precise role of EmbA
and EmbB in mycobacteria.
The analysis of the M. smegmatisDaftC mutant to date
and based on the Ara : Gal ratio would suggest that the
residual arabinan segment in the mutant consists of
approximately ﬁve Araf residues: b-D-Araf-(1→2)-a-D-
Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf
located at three branches on the galactan chain (Besra
et al., 1995; Alderwick et al., 2005). This is consistent with
the recent primary structure of AG (Bhamidi et al., 2008),
with a ‘non-variable’ terminal non-reducing Ara17 motif,
introduction of a 3,5-Araf residue distal to this non-
reducing end by AftC and further extension by a linear
a(1→5)Araf domain (Fig. 10). The latter appears to be
variable (up to 12/13 residues). However, based on
M. smegmatisDaftC and the subsequentAra : Gal compo-
sitional analysis a dominant Ara22/Ara23 motif would be
consistent with recent (Bhamidi et al., 2008) and previous
(Besra et al., 1995) structural data on AG and this is
represented in terms of biosynthetic considerations in
Fig. 10. It is also possible that AftC or a second distinct
a(1→3) arabinosfuranosyltransferase (shown as AftD in
Fig. 10) may be involved in late stages of AG synthesis,
i.e. the non-reducing Ara6 motif and is consistent with our
data and the model presented in Fig. 10.
The discovery of AftC has now shed new light on the
key arabinofuranosyltransferases to build an arabinan
domain typical for Corynebacterianae. In this context, the
genomic organization in the genomes of the Corynebac-
terianae sequenced is intriguing, revealing high synteny
of the M. tuberculosis aftC locus to the maps of all other
Mycobacterium and Corynebacterium species. The iden-
tiﬁcation of new cell wall biosynthetic drug targets is of
Fig. 8. Arabinofuranosyltransferase activity utilizing an Ara5 acceptor and membranes prepared from M. smegmatis, M. smegmatisDaftC and
M. smegmatisDaftC pMV261-Mt-aftC.
A. Arabinofuranosyltransferase activity was determined using the synthetic Ara5 acceptor in a cell-free assay with and without EMB
(1 mg ml
-1). The products reﬂective of three independent enzyme preparations and assays were re-suspended prior to scintillation counting
(10%) and the remaining subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in isopropanol/acetic acid/water (8/1/1/,
v/v/v) with the reaction product X visualized by autoradiography. The TLC autoradiogram is representative of three independent experiments.
B. Ara5 and Ara6 (Appelmelk et al., 2008) acceptor standards were subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in
isopropanol/acetic acid/water (8/1/1/, v/v/v) with the reaction products visualized by staining with a-naphthol followed by charring.
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TB. This newly discovered DPA-dependent arabinofura-
nosyl transferase represents, along with a straightforward
in vitro enzyme assay, a promising candidate for further
exploitation as a potential drug target.
Experimental procedures
Bacterial strains and growth conditions
Corynebacterium glutamicum ATCC 13 032 (referred to the
remainder of the text as C. glutamicum) and Escherichia
coli DH5amcr were grown in Luria–Bertani broth (LB, Difco)
at 30°C and 37°C respectively. The recombinant strains
generated in this study were grown on complex brain–heart
infusion medium (BHI, Difco), and the salt medium CGXII
used for C. glutamicum as described (Eggeling and Reyes,
2005). Kanamycin and ampicillin were used at a concentra-
tion of 50 mgm l
-1. M. smegmatis strains were grown in
tryptic soy broth (TSB; Difco), containing 0.005% Tween80
(TSBT). Solid media were made by adding 1.5% agar to the
above-mentioned broths. The concentrations of antibiotics
used for M. smegmatis were 100 mgm l
-1 for hygromycin
and 20 mgm l
-1 for kanamycin. Minimal inhibitory concentra-
tions were determined by plating cells on solid media
supplemented with various concentrations of EMB, rifampi-
cin and chloramphenicol. The minimal inhibitory concentra-
tion was deﬁned as the ﬁrst concentration of drug that
would inhibit 100% of growth after 5 days of incubation
(Belanger et al., 1996). M. tuberculosis H37Rv DNA was
obtained from the NIH Tuberculosis Research Materials and
Vaccine Testing Contract at Colorado State University. All
other chemicals were of reagent grade and obtained from
Sigma-Aldrich.
Construction of plasmids and strains
Approximately 1 kb of upstream and downstream ﬂanking
sequences of MSMEG2785 were PCR ampliﬁed from
Fig. 9. GC characterization of in vitro synthesized product X from the arabinofuranosyltransferase assays utilizing the Ara5 acceptor.
A. GC analysis of the partially per-O-methylated, per-O-acetylated alditol acetate derivative of product X obtained from assays containing
membranes prepared from either M. smegmatis, M. smegmatisDaftC or M. smegmatisDaftC pMV261-Mt-aftC (Sassaki et al., 2005).
B. Panel illustrates the structure(s) of product X.
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2155 genomic DNA using the primer pairs
MS2785LL (TTTTTTTTCCATAAATTGGATCCGCTGACCG
ACCTCATC) and MS2785LR (TTTTTTTTCCATTTCTTGGC
GAGCCCGAGCTTGAAGTTG), and MS2785RL (TTTTT
TTTCCATAGATTGGTTCCTGCTGCTGTCCCTTGG) and
MS2785RR (TTTTTTTTCCATCTTTTGGCGAACTCAGC
GGCGATTCAC) respectively (all primers are given in 5′
to 3′ direction). Following restriction digestion of the primer
incorporated Van91I sites, the PCR fragments were
cloned into Van91I-digested p0004S to yield the knockout
plasmid pDMSMEG2785 which was then packaged into
the temperature-sensitive mycobacteriophage phAE159 as
described previously (Bardarov et al., 2002) to yield phasmid
DNA of the knockout phage phDMSMEG2785. Generation of
high titre phage particles and specialized transduction were
performed as described earlier (Stover et al., 1991; Bardarov
et al., 2002). Deletion of MSMEG2785 in one hygromycin-
resistant transductant was conﬁrmed by Southern blot. To
enable expression of MSMEG2785 and Rv2673, in the dele-
tion mutant, these were ampliﬁed using primer pairs designed
for subsequent cloning into the mycobacterial-shuttle vector
pMV261 (Stover et al., 1991). All cloned fragments were veri-
ﬁed by sequencing.
To construct the deletion vector pK19mobsacBDaftC (NCgl
1822), cross-over PCR was applied with primer pairs AB
(A, CGTTAAGCTTCGATCTTGTTGATGTGTGGCATCACA
CG; B, CCCATCCACTAAACTTAAACAGCGCCATCAACAA
CATGG) and CD (C, TGTTTAAGTTTAGTGGATGGGTGATC
CAACGCACGACCATC; D, GCATGGATCCACGCATACCG
AGGGAAAGATCTTC) and C. glutamicum genomic DNA as
template. Both ampliﬁed products were used in a second
PCR with primer pairs AD to generate a 656 bp fragment
consisting of sequences adjacent to Cg-aftC, which was
ligated with BamHI–HindIII-cleaved pK19mobsacB. All plas-
mids were conﬁrmed by sequencing. The chromosomal dele-
tion of Cg-aftC was performed as described previously using
two rounds of positive selection (Schafer et al., 1994), and its
successful deletion was veriﬁed by use of two different primer
pairs.
Isolation of the mAGP complex, glycosyl composition
and linkage analysis of alditol acetates by GC and
GC/MS
The thawed cells were re-suspended in phosphate-buffered
saline containing 2% Triton X-100 (pH 7.2), disrupted by soni-
caton and centrifuged at 27 000 g (Besra et al., 1995; Alder-
wick et al., 2005). The pelleted material was extracted three
times with 2% SDS in phosphate-buffered saline at 95°C for
1 h, washed with water, 80% (v/v) acetone in water and
acetone, and ﬁnally lyophilized to yield a highly puriﬁed cell
wall preparation (Besra et al., 1995; Alderwick et al., 2005).
Cell wall or per-O-methylated cell wall preparations (Alder-
wick et al., 2005) were hydrolysed in 2 M TFA, reduced with
NaB
2H4 and the resultant alditols per-O-acetylated and exam-
ined by GC and GC/MS as described previously (Besra et al.,
1995; Alderwick et al., 2005).
Extraction and analysis of cell wall-bound mycolic acids
In terms of M. smegmatis strains equivalent amounts of
freeze-dried bacilli (100 mg) were processed as described
Fig. 10. Mycobacterial arabinan biosynthesis and the role of AftC.
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CHCl3/CH3OH/H2O (10:10:3, v/v/v) extractions for 4 h at
50°C in the analysis of cell wall-associated lipids, and
cell wall-bound MAMEs. Alternatively, M. smegmatis and
C. glutamicum cultures (5 ml) were grown and metabolically
labelled at mid-logarithmic phase of growth using 1 mCi ml
-1
[1,2-
14C]acetate (50–62 mCi mmol
-1, GE Healthcare, Amer-
sham Bioscience) for 4 h at either 30°C or 37°C with gentle
shaking, harvested, washed and freeze-dried. Cells were
then extracted by two consecutive extractions with 2 ml
of CHCl3/CH3OH/H2O (10:10:3, v/v/v) for 4 h at 50°C to
provide cell wall-associated lipids and analysed as
described previously (Seidel et al., 2007a). The crude lipid
extracts were re-suspended in CHCl3/CH3OH (2:1) and
equivalent aliquots (50 000 cpm) analysed by TLC using
silica gel plates (5735 silica gel 60F254, Merck) developed
in CHCl3/CH3OH/NH4OH (80:20:2, v/v/v) to separate [
14C]-
labelled TDM and phospholipids (Mikusova et al., 1995).
Lipids were visualized by autoradiography by overnight
exposure of Kodak X-Omat AR ﬁlm to the TLC plates to
reveal labelled lipids, quantiﬁed by phosphorimaging and
compared with know standards (Mikusova et al., 1995).
The bound MAMEs/CMAMEs from the above de-lipidated
extracts were released by the addition of 2 ml of 5%
aqueous solution of tetra-butyl ammonium hydroxide fol-
lowed by overnight incubation at 100°C. After cooling, water
(2 ml), CH2Cl2 (4 ml) and CH3I (500 ml) were added and
mixed thoroughly for 30 min. The lower organic phase was
recovered following centrifugation and washed three times
with water (4 ml), dried and re-suspended in diethyl ether
(4 ml). After centrifugation the clear supernatant was again
dried and re-suspended in CH2Cl2 (100 ml). An aliquot (5 ml)
from each strain was subjected to scintillation counting and
an equivalent (5 ml) aliquot analysed by TLC using silica gel
plates (5735 silica gel 60F254, Merck), developed in petro-
leum ether/acetone (95:5, v/v) and either visualized by auto-
radiography by exposure of Kodak X-Omat AR ﬁlm to the
TLC plates to reveal [14C]-labelled MAMEs/CMAMEs, or
charred following spraying with 5% molybdophosphoric acid
in ethanol at 100°C and compared with know standards.
Arabinofuranosyltransferase activity with membrane
preparations of M. smegmatis, M. smegmatis
pMV261-Mt-aftC, M. smegmatisDaftC and
M. smegmatisDaftC pMV261-Mt-aftC
Membranes were prepared as described previously (Lee
et al., 1997; Alderwick et al., 2006a) and re-suspended in
50 mM MOPS (pH 7.9), containing 5 mM b-mercaptoethanol
and 10 mM MgCl2 (buffer A) to a ﬁnal concentration
of 15–10 mg ml
-1. The neoglycolipid acceptors used in
this study were a-D-Araf-(1→5)-a-D-Araf-(1→5)-a-D-Araf-
(1→5)-a-D-Araf-(1→5)-a-D-Araf-O-(CH2)8NH2 (Ara5, see Sup-
plementary material) and a-D-Araf-(1→5)-a-D-Araf-O-
(CH2)7CH3 (Ara2) (Lee et al., 1995; 1998). The acceptors
(either Ara2 or Ara5) and DP[
14C]A (Lee et al., 1995; 1998)
(stored in CHCl3/CH3OH, 2:1, v/v) were aliquoted into 1.5 ml
eppendorf tubes to a ﬁnal concentration of 2 mM and
200 000 cpm (90 mM), respectively, and dried under nitro-
gen. The arabinofuranosyltransferase assay was carried out
as described previously (Lee et al., 1997) with modiﬁca-
tions. IgePal
TM (Sigma-Aldrich) was added (0.1%, v/v) with
the appropriate amount of buffer A (ﬁnal volume 80 ml).
Tubes were sonicated for 15 min to re-suspend lipid linked
substrates and then mixed with the remaining assay
components, which included membrane protein from
either M. smegmatis, M. smegmatis pMV261-Mt-aftC
M. smegmatisDaftC or M. smegmatisDaftC pMV261-Mt-aftC
(1 mg), 1 mM ATP, 1 mM NADP and in some cases EMB
(0–1 mg ml
-1). Assays were incubated for 1 h at 37°C and
quenched by the addition of 533 ml CHCl3/CH3OH (1:1, v/v).
After mixing and centrifugation at 27 000 g for 15 min at
4°C, the supernatant was removed and dried under nitro-
gen. The residue was then re-suspended in 700 mlo f
CH3CH2OH/H2O (1:1, v/v) and loaded onto a 1 ml SepPak
strong anion exchange cartridge (Supelco), pre-equilibrated
with CH3CH2OH/H2O (1:1, v/v). The column was washed
with 2 ml CH3CH2OH and the eluate collected, dried and
partitioned between the two phases arising from a mixture
of n-butanol (3 ml) and water (3 ml). The resulting organic
phase was recovered following centrifugation at 3500 g and
the aqueous phase again extracted twice with 3 ml of water-
saturated n-butanol. The pooled extracts were back-washed
twice with n-butanol-saturated water (3 ml). The n-butanol
fraction was dried and re-suspended in 200 ml butanol. The
extracted radiolabelled material was quantiﬁed by liquid
scintillation counting using 10% of the labelled material and
5 ml of EcoScintA (National Diagnostics, Atlanta). The incor-
poration of [
14C]Araf was determined by subtracting counts
present in control assays (incubations in the absence of
acceptor). The remaining labelled material was subjected to
thin-layer chromatography (TLC) using either isopropanol/
acetic acid/water (8:1:1, v/v/v) for the assays utilizing the
Ara5 acceptor or CHCl3/CH2OH/H2O/NH4OH (65:25:3.6:0.5,
v/v/v/v) in the case of the Ara2 acceptor on aluminum-
backed Silica Gel 60 F254 plates (Merck, Darmstadt,
Germany). Autoradiograms were obtained by exposing
TLCs to X-ray ﬁlm (Kodak X-Omat) for 3 days.
Characterization of a(1,3)-arabinofuranosyltransferase
activity with membranes prepared from M. smegmatis,
M. smegmatisDaftC and M. smegmatisDaftC
pMV261-Mt-aftC
Large-scale reaction mixtures containing cold DPA (200 mg,
0.75 mM) (Lee et al., 1997) and 50 mM of the acceptor Ara5
were mixed and given an initial incubation at 37°C with
membranes prepared from either M. smegmatis, M. smeg-
matisDaftC or M. smegmatisDaftC pMV261-Mt-aftC for 1 h.
The assays were replenished with fresh membranes (1 mg)
and re-incubated for 1 h at 37°C with the entire process
repeated thrice. Products were extracted from reaction mix-
tures by n-butanol/water phase separation as described
earlier to extract products. Products were applied to pre-
parative TLC plates, developed in isopropanol/acetic
acid/water (8:1:1, v/v/v) and sprayed with 0.01% 1,6-
diphenylhexatriene in petroleum-ether/acetone (9:1, v/v),
and the products localized under long-wave (366 nm) UV
light (Lee et al., 1997). The plate was then re-developed in
toluene to remove the reagent and the bands recovered
from the plates by extraction with n-butanol. The butanol
phases were washed with water saturated with n-butanol
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2005) and GC/MS as described (Lee et al., 1997; Alderwick
et al., 2006a).
Acknowledgements
H.L.B. is a Medical Research Council Quota Student. G.S.B.
acknowledges support in the form of a Personal Research
Chair from Mr James Bardrick, Royal Society Wolfson
Research Merit Award, as a former Lister Institute-Jenner
Research Fellow, the Medical Research Council and The
Wellcome Trust (081569/Z/06/Z). A.B. is supported by a
Career Development Award from the Medical Research
Council. The contributions of T.L.L. and Y.B. to this work were
supported by the Alberta Ingenuity Centre for Carbohydrate
Science and the Natural Sciences and Engineering Research
Council of Canada. The authors would also like to thank W.R.
Jacobs Jr. and Tsungda Hsu (Albert Einstein College of Medi-
cine, New York) for the gift of plasmid p0004S.
References
Alderwick, L.J., Radmacher, E., Seidel, M., Gande, R.,
Hitchen, P.G., Morris, H.R., et al. (2005) Deletion of
Cg-emb in corynebacterianeae leads to a novel truncated
cell wall arabinogalactan, whereas inactivation of Cg-ubiA
results in an arabinan-deﬁcient mutant with a cell wall
galactan core. J Biol Chem 280: 32362–32371.
Alderwick, L.J., Seidel, M., Sahm, H., Besra, G.S., and
Eggeling, L. (2006a) Identiﬁcation of a novel arabino-
furanosyltransferase (AftA) involved in cell wall arabinan
biosynthesis in Mycobacterium tuberculosis. J Biol Chem
281: 15653–15661.
Alderwick, L.J., Dover, L.G., Seidel, M., Gande, R., Sahm, H.,
Eggeling, L., and Besra, G.S. (2006b) Arabinan-deﬁcient
mutants of Corynebacterium glutamicum and the con-
sequent ﬂux in decaprenylmonophosphoryl-D-arabinose
metabolism. Glycobiology 16: 1073–1081.
Amin, A.G., Goude, R., Shi, L., Zhang, J., Chatterjee, D., and
Parish, T. (2008) EmbA is an essential arabinosyltrans-
ferase in Mycobacterium tuberculosis. Microbiology 154:
240–248.
Appelmelk, B.J., den Dunnen, J., Driessen, N.N., Ummels,
R., Pak, M., Nigou, J., et al. (2008) The mannose cap of
mycobacterial lipoarabinomannan does not dominate the
Mycobacterium–host interaction. Cell Microbiol 10: 930–
944.
Bardarov, S., Bardarov, S., Jr, Pavelka, M.S., Jr, Sambanda-
murthy, V., Jr, Larsen, M., Tufariello, J., et al. (2002) Spe-
cialized transduction: an efficient method for generating
marked and unmarked targeted gene disruptions in Myco-
bacterium tuberculosis, M. bovis BCG and M. smegmatis.
Microbiology 148: 3007–3017.
Belanger,A.E.,Besra,G.S.,Ford,M.E.,Mikusova,K.,Belisle,
J.T., Brennan, P.J., and Inamine, J.M. (1996) The embAB
genesofMycobacteriumaviumencodeanarabinosyltrans-
ferase involved in cell wall arabinan biosynthesis that is the
target for the antimycobacterial drug ethambutol. Proc Natl
Acad Sci USA 93: 11919–11924.
Besra, G.S., Khoo, K.H., McNeil, M.R., Dell, A., Morris, H.R.,
and Brennan, P.J. (1995) A new interpretation of the struc-
ture of the mycolyl-arabinogalactan complex of Mycobac-
terium tuberculosis as revealed through characterization of
oligoglycosylalditol fragments by fast-atom bombardment
mass spectrometry and
1H nuclear magnetic resonance
spectroscopy. Biochemistry 34: 4257–4266.
Bhamidi, S., Scherman, M.S., Rithner, C.D., Prenni, J.E.,
Chatterjee, D., Khoo, K.H., and McNeil, M.R. (2008) The
identiﬁcation and location of succinyl residues and the
characterization of the interior arabinan region allows for a
model of the compete primary structure of Mycobacterium
tuberculosis mycolyl arabinogalactan. J Biol Chem 283:
12992–13000.
Bhatt, A., Kremer, L., Dai, A.Z., Sacchettini, J.C., and Jacobs,
W.R., Jr (2005) Conditional depletion of KasA, a key
enzyme of mycolic acid biosynthesis, leads to mycobacte-
rial cell lysis. J Bacteriol 187: 7596–7606.
Brennan, P.J., and Nikaido, H. (1995) The envelope of
mycobacteria. Annu Rev Biochem 64: 29–63.
Brudno, M., Chapman, M., Gottgens, B., Batzoglou, S., and
Morgenstern, B. (2003) Fast and sensitive multiple align-
ment of large genomic sequences. BMC Bioinformatics 4:
66.
Daffé, M., Brennan, P.J., and McNeil, M. (1990) Predominant
structural features of the cell wall arabinogalactan of
Mycobacterium tuberculosis as revealed through char-
acterization of oligoglycosyl alditol fragments by gas
chromatography/mass spectrometry and by
1H and
13C
NMR analyses. J Biol Chem 265: 6734–6743.
Dover, L.G., Cerdeno-Tarraga, A.M., Pallen, M.J., Parkhill, J.,
and Besra, G.S. (2004) Comparative cell wall core biosyn-
thesis in the mycolated pathogens, Mycobacterium tuber-
culosis and Corynebacterium diphtheriae. FEMS Microbiol
Rev 28: 225–250.
Dye, C. (2006) Global epidemiology of tuberculosis. Lancet
367: 938–940.
Eggeling, L., and Reyes, O. (2005) Experiment. In Handbook
of Corynebacterium glutamicum. Eggeling, L., and Bott, M.
(eds). Boca Raton, FL: CRC Press, Taylor Francis Group,
pp. 535–566.
Escuyer, V.E., Lety, M.A., Torrelles, J.B., Khoo, K.H., Tang,
J.B., Rithner, C.D., et al. (2001) The role of the embA and
embB gene products in the biosynthesis of the terminal
hexaarabinofuranosyl motif of Mycobacterium smegmatis
arabinogalactan. J Biol Chem 276: 48854–48862.
Gande, R., Gibson, K.J., Brown, A.K., Krumbach, K., Dover,
L.G., Sahm, H., et al. (2004) Acyl-CoA carboxylases
(accD2 and accD3), together with a unique polyketide syn-
thase (Cg-pks), are key to mycolic acid biosynthesis in
Corynebacterianeae such as Corynebacterium glutamicum
and Mycobacterium tuberculosis. J Biol Chem 279: 44847–
44857.
Guvener, Z.T., and McCarter, L.L. (2003) Multiple regulators
control capsular polysaccharide production in Vibrio
parahaemolyticus. J Bacteriol 185: 5431–5441.
Kaye, K., and Frieden, T.R. (1996) Tuberculosis control:
the relevance of classic principles in an era of acquired
immunodeﬁciency syndrome and multidrug resistance.
Epidemiol Rev 18: 52–63.
Lee, R.E., Mikusova, K., Brennan, P.J., and Besra, G.S.
(1995) Synthesis of the arabinose aonor b-D-
1204 H. L. Birch etal. 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 1191–1206arabinofuranosyl-1-monophosphoryldecaprenol, develop-
ment of a basic arabinosyl-transferase assay, and
identiﬁcation of ethambutol as an arabinosyltransferase
inhibitor. J Am Chem Soc 117: 11829–11832.
Lee, R.E., Brennan, P.J., and Besra, G.S. (1997) Mycobac-
terial arabinan biosynthesis: the use of synthetic arabino-
side acceptors in the development of an arabinosyl transfer
assay. Glycobiology 7: 1121–1128.
Lee, R.E., Brennan, P.J., and Besra, G.S. (1998) Synthesis
of b-D-arabinofuranosyl-1-monophosphoryl polyprenols:
examination of their function as mycobacterial arabinosyl
transferase donors. Bioorg Med Chem Lett 8: 951–954.
Liu, J., and Mushegian, A. (2003) Three monophyletic
superfamilies account for the majority of the known
glycosyltransferases. Protein Sci 12: 1418–1431.
McNeil, M., Daffe, M., and Brennan, P.J. (1990) Evidence for
the nature of the link between the arabinogalactan and
peptidoglycan of mycobacterial cell walls. J Biol Chem 265:
18200–18206.
McNeil, M., Daffe, M., and Brennan, P.J. (1991) Location
of the mycolyl ester substituents in the cell walls of
mycobacteria. J Biol Chem 266: 13217–13223.
Mikusova, K., Slayden, R.A., Besra, G.S., and Brennan, P.J.
(1995) Biogenesis of the mycobacterial cell wall and the
site of action of ethambutol. Antimicrob Agents Chemother
39: 2484–2489.
Mills, J.A., Motichka, K., Jucker, M., Wu, H.P., Uhlik, B.C.,
Stern, R.J., et al. (2004) Inactivation of the mycobacterial
rhamnosyltransferase, which is needed for the formation of
the arabinogalactan-peptidoglycan linker, leads to irrevers-
ible loss of viability. J Biol Chem 279: 43540–43546.
Minnikin, D.E. (1982) Lipids: complex lipids, their chemistry,
biosynthesis and roles. In The Biology of the Mycobacteria.
Ratledge, C., and Stanford, J. (eds). London: Academic
Press, pp. 95–184.
Mishra, A.K., Alderwick, L.J., Rittmann, D., Tatituri, R.V.,
Nigou, J., Gilleron, M., et al. (2007) Identiﬁcation of an
a(1→6) mannopyranosyltransferase (MptA), involved in
Corynebacterium glutamicum lipomanann biosynthesis,
and identiﬁcation of its orthologue in Mycobacterium
tuberculosis. Mol Microbiol 65: 1503–1517.
Mishra, A.K., Alderwick, L.J., Rittmann, D., Wang, C., Bhatt,
A., Jacobs, W.R., Jr, et al. (2008) Identiﬁcation of a novel
a(1→6) mannopyranosyltransferase (MptB) from Coryne-
bacterium glutamicum by deletion of a conserved gene,
NCgl1505, affords a lipomanann- and lipoarabinomann-
deﬁcient mutant. Mol Microbiol 68: 1595–1613.
Pan, F., Jackson, M., Ma, Y., and McNeil, M. (2001) Cell wall
core galactofuran synthesis is essential for growth of
mycobacteria. J Bacteriol 183: 3991–3998.
Paolo, W.F., Jr and Nosanchuk, J.D. (2004) Tuberculosis in
New York city: recent lessons and a look ahead. Lancet
Infect Dis 4: 287–293.
Parish, T., Roberts, G., Laval, F., Schaeffer, M., Daffe, M.,
and Duncan, K. (2007) Functional complementation of the
essential gene fabG1 of Mycobacterium tuberculosis by
Mycobacterium smegmatis fabG but not Escherichia coli
fabG. J Bacteriol 189: 3721–3728.
Portevin, D., De Sousa-D’Auria, C., Houssin, C., Grimaldi, C.,
Chami, M., Daffe, M., and Guilhot, C. (2004) A polyketide
synthase catalyzes the last condensation step of mycolic
acid biosynthesis in mycobacteria and related organisms.
Proc Natl Acad Sci USA 101: 314–319.
Radmacher, E., Stansen, K.C., Besra, G.S., Alderwick, L.J.,
Maughan, W.N., Hollweg, G., et al. (2005) Ethambutol, a
cell wall inhibitor of Mycobacterium tuberculosis, elicits
1-glutamate efflux of Corynebacterium glutamicum.
Microbiology 151: 1359–1368.
Sassaki, G.L., Iacaomini, M., and Gorin, P.A.J. (2005)
Methylation-GC-MS analysis of arabinofuranose-and
galactofuranose-containing structures; rapid synthesis of
partially O-methylated alditol acetates. AnAcad Bras Cienc
77: 223–234.
Schafer, A., Tauch, A., Jager, W., Kalinowski, J., Thierbach,
G., and Puhler, A. (1994) Small mobilizable multi-purpose
cloning vectors derived from the Escherichia coli plasmids
pK18 and pK19: selection of deﬁned deletions in the
chromosome of Corynebacterium glutamicum. Gene 145:
69–73.
Seidel, M., Alderwick, L.J., Birch, H.L., Sahm, H., Eggeling,
L., and Besra, G.S. (2007a) Identiﬁcation of a novel ara-
binofuranosyltransferaseAftB involved in a terminal step of
cell wall arabinan biosynthesis in Corynebacterianeae,
such as Corynebacterium glutamicum and Mycobacterium
tuberculosis. J Biol Chem 282: 14729–14740.
Seidel, M., Alderwick, L.J., Sahm, H., Besra, G.S., and Egg-
eling, L. (2007b) Topology and mutational analysis of the
single Emb arabinofuranosyltransferase of Corynebacte-
rium glutamicum as a model of Emb proteins of Mycobac-
terium tuberculosis. Glycobiology 17: 210–219.
Shah, N.S., Wright, A., Bai, G.H., Barrera, L., Boulahbal, F.,
Martin-Casabona, N., et al. (2007) Worldwide emergence
of extensively drug-resistant tuberculosis. Emerg Infect Dis
13: 380–387.
Stover, C.K., de la Cruz, V.F., Fuerst, T.R., Burlein, J.E.,
Benson, L.A., Bennett, L.T., et al. (1991) New use of BCG
for recombinant vaccines. Nature 351: 456–460.
Takayama, K., and Kilburn, J.O. (1989) Inhibition of synthe-
sis of arabinogalactan by ethambutol in Mycobacterium
smegmatis. Antimicrob Agents Chemother 33: 1493–
1499.
Telenti, A., Philipp, W.J., Sreevatsan, S., Bernasconi, C.,
Stockbauer, K.E., Wieles, B., et al. (1997) The emb
operon, a gene cluster of Mycobacterium tuberculosis
involved in resistance to ethambutol. Nat Med 3: 567–570.
Vilcheze, C., Morbidoni, H.R., Weisbrod, T.R., Iwamoto, H.,
Kuo, M., Sacchettini, J.C., and Jacobs, W.R. Jr (2000)
Inactivation of the inhA-encoded fatty acid synthase II
(FASII) enoyl-acyl carrier protein reductase induces accu-
mulation of the FASI end products and cell lysis of Myco-
bacterium smegmatis. J Bacteriol 182: 4059–4067.
Wolucka, B.A., McNeil, M.R., de Hoffmann, E., Chojnacki, T.,
and Brennan, P.J. (1994) Recognition of the lipid inter-
mediate for arabinogalactan/arabinomannan biosynthesis
and its relation to the mode of action of ethambutol on
mycobacteria. J Biol Chem 269: 23328–23335.
Zhang, N., Torrelles, J.B., McNeil, M.R., Escuyer, V.E., Khoo,
K.H., Brennan, P.J., and Chatterjee, D. (2003) The Emb
proteins of mycobacteria direct arabinosylation of lipoara-
binomannan and arabinogalactan via an N-terminal
recognition region and a C-terminal synthetic region. Mol
Microbiol 50: 69–76.
Identification of a novel arabinofuranosyltransferase 1205
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 1191–1206Supplementary material
This material is available as part of the online article from:
http://www.blackwell-synergy.com/doi/abs/10.1111/
j.1365-2958.2008.06354.x
(This link will take you to the article abstract).
Please note: Blackwell Publishing is not responsible for the
content or functionality of any supplementary materials sup-
plied by the authors. Any queries (other than missing mate-
rial) should be directed to the corresponding author for the
article.
1206 H. L. Birch etal. 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 1191–1206